FDA Inspection 1080606 — Apitoria Pharma Private Limited

Apitoria Pharma Private Limited — FEI 3004021253

The FDA completed an inspection of Apitoria Pharma Private Limited on February 2, 2019 in Sangareddy. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
February 2, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Sangareddy (India)